<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-11-11 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-11-11/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-11-11"><meta property="og:description" content="ğŸ“… Daily Report - 2025-11-11 ä»Šæ—¥ç­›é€‰å‡º 51 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-11-11T00:00:00+00:00"><meta property="article:modified_time" content="2025-11-11T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week462025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-11-11"><meta itemprop=description content="ğŸ“… Daily Report - 2025-11-11 ä»Šæ—¥ç­›é€‰å‡º 51 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-11-11T00:00:00+00:00"><meta itemprop=dateModified content="2025-11-11T00:00:00+00:00"><meta itemprop=wordCount content="2723"><meta itemprop=keywords content="Research,Daily,Week462025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-11-11"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-11-11 ä»Šæ—¥ç­›é€‰å‡º 51 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-11</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-11-11T00:00:00Z>2025-11-11</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</a></li><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </a></li><li><a href=#-å­¦ç‚¹ç”Ÿä¿¡>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-11-11>ğŸ“… Daily Report - 2025-11-11</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>51</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>4</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
è‚¿ç˜¤ç¥ç»æµ¸æ¶¦æœºåˆ¶åŠä¸æŠ—PD-1æ²»ç–—å“åº”ä¸ä½³çš„å…³è”ï¼Œä»¥åŠEP300è°ƒæ§æŠ—è‚¿ç˜¤å…ç–«ååº”çš„æ–°æœºåˆ¶ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚¿ç˜¤ç¥ç»æµ¸æ¶¦ï¼šæ­ç¤ºå…¶ä¿ƒç™Œæœºåˆ¶ï¼Œå¹¶æ¢ç´¢å…¶ä¸æŠ—PD-1æ²»ç–—å“åº”çš„å…³ç³»ã€‚</li><li>æ³›ç™Œä»£è°¢åˆ†æï¼šèšç„¦è·¨å¾ªç¯ç³»ç»Ÿå’Œç»„ç»‡çš„ä»£è°¢ç ”ç©¶ï¼Œç‰¹åˆ«æ˜¯å˜Œå‘¤å’Œä¸™é…¸ä»£è°¢ã€‚</li><li>æŠ—è‚¿ç˜¤å…ç–«ï¼šç ”ç©¶EP300åœ¨è°ƒæ§æŠ—è‚¿ç˜¤å…ç–«ååº”ä¸­çš„ä½œç”¨ï¼Œä»¥åŠCD8Teffç»†èƒæ¯”ä¾‹ä¸æ²»ç–—ååº”çš„å…³ç³»ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>å•ç»†èƒä¸ç©ºé—´è½¬å½•ç»„è”åˆåˆ†æï¼šiStarä½œä¸ºæ–°å‹åˆ†æå·¥å…·ï¼ŒGiotto Suiteæä¾›å¤šå°ºåº¦ã€æŠ€æœ¯æ— å…³çš„ç”Ÿæ€ç³»ç»Ÿã€‚</li><li>æ•°å­—ç—…ç†å­¦ï¼šå¼€å‘ç”¨äºè‚ºç™Œè¯Šæ–­å’Œé¢„åçš„æ–°å‹ç®—æ³•ã€‚</li></ul><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
Direct RNA sequencing é¦–æ¬¡æ­ç¤ºäº†çœŸæ ¸ç»†èƒçš„RNAç»“æ„ï¼Œå¹¶é˜æ˜äº†N1-ç”²åŸºå‡å°¿è‹·å¯¹ç¿»è¯‘åŠ¨æ€çš„ç›´æ¥è°ƒæ§ä½œç”¨ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>è‚¿ç˜¤åˆ†å­æœºåˆ¶</strong>ï¼šæ¢ç´¢äº†FETé‡æ’è½¯ç»„ç»‡è‚Œä¸Šçš®ç˜¤çš„è¡¨è§‚é—ä¼ ç‰¹å¾ï¼Œæ­ç¤ºäº†miR-214-3påœ¨èƒƒç™Œä¸­çš„è½¬å½•è°ƒæ§ä½œç”¨ï¼Œå¹¶ç ”ç©¶äº†SETD8æŠ‘åˆ¶å‰‚å¯¹ç–±ç–¹ç—…æ¯’åŸºå› ç»„å¯åŠæ€§çš„å½±å“ã€‚</li><li><strong>å…ç–«ä¸ç‚ç—‡</strong>ï¼šæ¯”è¾ƒäº†LADAä¸1å‹ç³–å°¿ç—…çš„å•ç»†èƒå…ç–«å›¾è°±ï¼Œæ¢è®¨äº†è¡€æ¸…æ·€ç²‰æ ·è›‹ç™½A1åœ¨èƒè†œç‚ä¸­çš„ä½œç”¨ï¼Œä»¥åŠAioloså¯¹Tç»†èƒåˆ†åŒ–åŠŸèƒ½çš„å½±å“ã€‚</li><li><strong>å‘è‚²ä¸åˆ†åŒ–</strong>ï¼šç ”ç©¶äº†ZNF263åœ¨èƒšèƒå¹²ç»†èƒå¤šèƒ½æ€§ç»´æŒä¸åˆ†åŒ–ä¸­çš„ä½œç”¨ï¼Œä»¥åŠHSD17B1çªå˜å¯¹å°é¼ åµå·¢åŸºå› è¡¨è¾¾çš„å½±å“ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>Direct RNA sequencing</strong>ï¼šå®ç°äº†å¯¹RNAç»“æ„å’Œç¿»è¯‘åŠ¨æ€çš„ç›´æ¥æµ‹åºåˆ†æã€‚</li><li><strong>å¤šç»„å­¦æ•´åˆ</strong>ï¼šç»“åˆATAC-seqå’ŒChIP-seqç­‰æŠ€æœ¯ï¼Œæ·±å…¥è§£æäº†åŸºå› ç»„å¯åŠæ€§ä¸è½¬å½•è°ƒæ§ã€‚</li></ul><h3 id=-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š</p></blockquote><ul><li><strong>Elacestrantåœ¨ESR1çªå˜è½¬ç§»æ€§ä¹³è…ºç™Œä¸­å±•ç°ä¼˜åŠ¿</strong>ï¼šå£æœé€‰æ‹©æ€§é›Œæ¿€ç´ å—ä½“é™è§£å‰‚elacestrantç›¸è¾ƒäºæ ‡å‡†å†…åˆ†æ³Œæ²»ç–—ï¼Œæ˜¾è‘—æé«˜äº†ESR1çªå˜MBCæ‚£è€…çš„æ— è¿›å±•ç”Ÿå­˜æœŸï¼ŒçœŸå®ä¸–ç•Œæ•°æ®è¿›ä¸€æ­¥è¯å®äº†å…¶ç–—æ•ˆã€‚</li><li><strong>è¡°è€å¾®ç¯å¢ƒé©±åŠ¨èƒ°è…ºç™Œå…ç–«æ’æ–¥ä¸è½¬ç§»</strong>ï¼šç”Ÿç‰©ä½“è¡°è€åŠ é€Ÿäº†èƒ°è…ºç™Œè¿›å±•ï¼Œè€å¹´è‚¿ç˜¤ç›¸å…³æˆçº¤ç»´ç»†èƒï¼ˆCAFï¼‰åˆ†æ³Œçš„ç»†èƒå¤–åŸºè´¨æ˜¯å½±å“å…¶å…ç–«æ’æ–¥å’Œè½¬ç§»çš„å…³é”®å› ç´ ã€‚</li></ul><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è¯„ä¼°elacestrantåœ¨çœŸå®ä¸–ç•ŒESR1çªå˜MBCæ‚£è€…ä¸­çš„åº”ç”¨åŠå…¶ä¸´åºŠåŸºå› ç»„é¢„æµ‹å› ç´ ã€‚</li><li>æ­ç¤ºè¡°è€å¾®ç¯å¢ƒï¼ˆç‰¹åˆ«æ˜¯è€å¹´CAFï¼‰åœ¨èƒ°è…ºç™Œå…ç–«æ’æ–¥å’Œè½¬ç§»ä¸­çš„ä½œç”¨æœºåˆ¶ã€‚</li><li>è¯„ä¼°å¤šåŸºå› æ£€æµ‹å’ŒpembrolizumabæŠ¥é”€æ”¿ç­–å¯¹è½¬ç§»æ€§é»‘è‰²ç´ ç˜¤æ‚£è€…åŠäººç¾¤å¥åº·çš„å½±å“ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>åˆ©ç”¨çœŸå®ä¸–ç•Œæ•°æ®ï¼ˆGuardantINFORMï¼‰è¯„ä¼°é¶å‘è¯ç‰©ç–—æ•ˆã€‚</li><li>åº”ç”¨ä¸å¹´é¾„ç›¸å…³çš„åŒåŸºå› åŸä½æ¨¡å‹ï¼Œç»“åˆè½¬å½•ç»„å­¦å’Œåˆ†æ³Œç»„å­¦åˆ†æï¼Œæ·±å…¥ç ”ç©¶è¡°è€å¯¹è‚¿ç˜¤çš„å½±å“ã€‚</li></ul><h3 id=-å­¦ç‚¹ç”Ÿä¿¡>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ­ç¤ºç¦»æ•£æ•°æ®ä¸‹ï¼Œé›¶å‡è®¾çš„på€¼åˆ†å¸ƒå¹¶éæ€»æ˜¯å‡åŒ€ï¼ŒæŒ‘æˆ˜äº†ä¼ ç»Ÿç»Ÿè®¡å­¦è®¤çŸ¥ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>ç¦»æ•£æ•°æ®på€¼åˆ†å¸ƒ</strong>ï¼šç ”ç©¶é›¶å‡è®¾ä¸‹ï¼Œç¦»æ•£å‹å˜é‡på€¼çš„çœŸå®åˆ†å¸ƒç‰¹å¾ã€‚</li><li><strong>ç»Ÿè®¡æ¨æ–­æ–¹æ³•</strong>ï¼šæ¢ç´¢ç¦»æ•£æ•°æ®ä¸‹æ›´å‡†ç¡®çš„ç»Ÿè®¡æ¨æ–­æ–¹æ³•ï¼Œé¿å…å› på€¼éå‡åŒ€åˆ†å¸ƒå¯¼è‡´çš„è¯¯åˆ¤ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>ç†è®ºæ¨å¯¼ä¸æ¨¡æ‹ŸéªŒè¯</strong>ï¼šé€šè¿‡ç†è®ºæ¨å¯¼å’Œæ¨¡æ‹Ÿå®éªŒï¼Œé¦–æ¬¡é‡åŒ–ç¦»æ•£æ•°æ®ä¸‹på€¼åˆ†å¸ƒçš„åç¦»ç¨‹åº¦ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“° å…¬ä¼—å· (18æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>Rè¯­è¨€ | å•ç»†èƒè”åˆç©ºé—´è½¬å½•ç»„å­¦çš„å¸¸è§åˆ†ææµç¨‹~</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šä½œå›¾ä¸«</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€ç©ºé—´è½¬å½•ç»„ã€ç©ºé—´ç»„å­¦ã€è½¬å½•ç»„</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2NTE1MzU4NQ==&amp;mid=2247523378&amp;idx=1&amp;sn=4d5ecd0c648ec38bd0946a76a74c42d9">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>é™¢å£«å›¢é˜Ÿåˆšå‘è¡¨åœ¨Cancer Cellï¼Œç»“åˆå•ç»†èƒå’Œç©ºè½¬æ­ç¤ºè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ä¿ƒç™Œæœºåˆ¶ã€‚å¤§çƒ­ç‚¹ä¸å®¹é”™è¿‡ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€cancerã€å•ç»†èƒ</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503915&amp;idx=3&amp;sn=9e07f0a606084f843f7755a78608e50e">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>7.7åˆ†1åŒºç”Ÿä¿¡ï¼Œå…¨æ–‡32ä¸ªFigureèšç„¦æœ€æ–°çƒ­ç‚¹ï¼šè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ã€‚å°ç¼–è®¤è¯çš„é«˜è´¨é‡ç”Ÿä¿¡æ–‡ç« ï¼ŒæŠ•ç¨¿åˆ°æ¥æ”¶ä»…ä¸¤ä¸ªå¤šæœˆï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503915&amp;idx=4&amp;sn=e54d070845d53c548a34b7f3d6e9bdb9">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>48.5åˆ†ï¼Œæ˜Ÿçº§çƒ­ç‚¹ï¼Œåˆšå‘å®ŒCancer cellåˆæ¥ä¸ªNatureï¼Œè‚¿ç˜¤ç¥ç»æµ¸æ¶¦ä¸æŠ— PD-1 æ²»ç–—å“åº”ä¸ä½³ç›¸å…³ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€cancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503915&amp;idx=2&amp;sn=87f3c61439a8c394676b72c49b814606">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>monocle2ä¹Ÿå¯ä»¥ç”¨äºbulk RNA-seqåˆ†æå—ï¼Ÿ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡æŠ€èƒ½æ ‘</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€RNAseq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼š100å¤šä¸ªbulkè½¬å½•ç»„ä¹Ÿèƒ½åšæ‹Ÿæ—¶åºå—ï¼Ÿ</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247546835&amp;idx=1&amp;sn=685ecc616460b11f7fa44a587fddcdff">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>10x Genomicsï¼šå°±è¿™ä¹Ÿèƒ½æš´æ¶¨ï¼Ÿ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå¾ªå› ç¼‰è¯</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼š10xã€genomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šâ€œåˆºæ¿€â€</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU3OTYwNjk1NA==&amp;mid=2247523329&amp;idx=1&amp;sn=7ccfaf5b21f007bec3cbb16e3ecae630">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>JITCï¼šç¨‹æ ¹å®/æ¨è¡¡å›¢é˜Ÿæ­ç¤º EP300 è°ƒæ§æŠ—è‚¿ç˜¤å…ç–«ååº”çš„æ–°æœºåˆ¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šä¸é¦™å­¦æœ¯</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649752&amp;idx=3&amp;sn=ce7bdd08050fe90707e244d2410492dc">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>ç©ºé—´ç»„å­¦ | Nat.Methods | Giotto Suiteï¼šä¸€ä¸ªå¤šå°ºåº¦ã€æŠ€æœ¯æ— å…³çš„ç©ºé—´å¤šç»„å­¦åˆ†æç”Ÿæ€ç³»ç»Ÿ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šBioJournal Link</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTMEã€ç©ºé—´ç»„å­¦</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503130&amp;idx=2&amp;sn=d2f8a3afbbd07c63f89a2fde73a5a1f7">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>æœ€æ–°çš„33+æ–‡ç« ï¼Œè·¨å¾ªç¯ç³»ç»Ÿå’Œç»„ç»‡çš„æ³›ç™Œä»£è°¢åˆ†æï¼Œå˜Œå‘¤ä»£è°¢ä¹Ÿæ˜¯ç«èµ·æ¥äº†ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šä¸œæ™“ç”Ÿç‰©</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTU2MzM2NA==&amp;mid=2247493000&amp;idx=1&amp;sn=126e466c78a709014e2f2b6c2e6adbfe">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>è¯¦è§£ï¼šä¸™é…¸ä»£è°¢</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå°æä»£è°¢</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šä¸™é…¸ä»£è°¢æ˜¯è‚ é“èŒç¾¤ä¸å®¿ä¸»ä¹‹é—´å¤æ‚äº’ä½œçš„é‡è¦ç»„æˆéƒ¨åˆ†ã€‚é€šè¿‡ä¸åŒèŒæ ªçš„ä»£è°¢ç‰¹æ€§åŠå®¿ä¸»çš„åˆ©ç”¨é€”å¾„ï¼Œä¸™é…¸åœ¨ç»´æŒå®¿ä¸»å¥åº·ã€è°ƒèŠ‚ä»£è°¢å’Œå…ç–«åŠŸèƒ½ä¸­å‘æŒ¥å…³é”®ä½œç”¨</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484020&amp;idx=1&amp;sn=c385540df7d01539f1103c31c0cd66bb">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 8 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E5%85%AC%E4%BC%97%E5%8F%B7>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (25æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡-1>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE300102 FETé‡æ’è½¯ç»„ç»‡è‚Œä¸Šçš®è‚¿ç˜¤æ¶µç›–å¹¿æ³›çš„ä¸´åºŠç—…ç†å’Œåˆ†å­è°±ï¼Œå…¶è¡¨è§‚é—ä¼ å­¦ç‰¹å¾ä¸çš®è‚¤å’Œå¤´é¢ˆéƒ¨è‚Œä¸Šçš®è‚¿ç˜¤ä¸åŒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€immuneã€immunityã€TMEã€metabolismã€metabolicã€metabolomeã€metabolomicsã€cardiacã€gliomaã€resistanceã€TCGAã€DepMapã€depmapã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€transcriptomeã€proteomeã€Bioconductorã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Josephine Dermawan ; Michael Michal ; Cristina AntonescuSeries Type : Methylation profiling by genome tiling arrayOrganism : Homo sapiensDNA methylation profiling from a multi-institutional cohort of 52 fusion-positive MET cases were analyzed. Pooled clinicopathological and outcome analysis with new and published cases (total 185 and 69 cases, respectively) was performed. The MET subgroups, EWSR1::KLF15, EWSR1/FUS::KLF17, EWSR1::PBX1, EWSR1::PBX3, EWSR1/FUS::POU5F1, SS18::POU5F1, and EWSR1::ZNF444, showed significant heterogeneity in age group, site, and histology. DNA methylation analysis revealed that fusion-positive MET were epigenetically related to each other and EWSR1/FUS::NFATC2 sarcomas, but entirely distinct from the epigenetically-related PLAG1-rearranged and salivary gland MET.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300102">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE300926 ç»¼åˆé•¿è¯»é•¿è½¬å½•ç»„åˆ†ææ­ç¤ºäº† miR-214-3p å¤±è°ƒä»‹å¯¼çš„èƒƒç™Œç»†èƒå¤šå±‚æ¬¡è½¬å½•æ”¹å˜</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€immuneã€immunityã€TMEã€cardiacã€gliomaã€resistanceã€TCGAã€DepMapã€depmapã€Hi-Cã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€spatial transcriptomicsã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€epigeneticã€epigenomeã€histoneã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ruijuan Xin ; Xiaoqin Ma ; Min Niu ; Qian Hao ; Hongliang Li ; Shengjuan HuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensLong-length sequencing has been widely used in cancer-related research for exploring transcriptome variations in human cancer in recent years. miR-214-3p, a microRNA, has been reported to have abnormal expression and play important regulation roles in diverse cancers. However, information about the genome-wide targets and action mechanisms of miR-214-3p in cancer cells is still limited. Here, long-read sequencing were performed to character the transcriptome variations after disturbing the expression of miR-214-3p in AGS cells, a gastric cancer cell line. The results showed that both miR-214-3p overexpression (OE) and suppression (KD) extensively increased or decreased expression level of a number of genes involved in apoptotic process and transcription at transcript level and gene level. In particular, both miR-214-3p KD and OE could increase or decrease on the expression levels of some target genes at the same direction. Moreover, miR-214-3p broadly regulated the alternative splicing of hundreds of genes with functions of cell division, cellular senescence and transcription regulation. In addition, the changes in the expression level of miR-214-3p can cause changes in the alternative polyadenylation and 3UTR lengths of the transcript. Taken together, these results indicated that miR-214-3p could mediate apoptosis by diverse modes in AGS cells, which adds to the understanding of the critical role of miR-214-3p in cancer cancer.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300926">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE308443 äººç±»å¤–å‘¨è¡€å•æ ¸ç»†èƒä¸­ä¸LPSåˆºæ¿€ç›¸å…³çš„å¯å˜å‰ªæ¥å’Œæ•´ä½“è½¬å½•ç»„å˜åŒ–</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€immuneã€TMEã€cardiacã€gliomaã€resistanceã€TCGAã€DepMapã€depmapã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€epigeneticã€epigenomeã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Kord Kober ; Esther Chavez Iglesias ; Anatol SucherSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensLipopolysaccharide (LPS) is a commonly used stimulant that induces an innate immune response, and serves as a model for studying inflammatory responses. Alternative splicing is key to gene expression and cell function, and is a key layer of gene regulation during disease progression and stress response. Although alternative splicing has been identified to play a role in response to LPS stimulation, a transcriptome wide ex vivo characterization of bulk PBMCs is lacking. Given the role of alternative splicing in the immune response is largely unexplored, understanding the role alternative splicing in the immune response can improve our understanding of gene regulatory processes and identify targets for treatment. The purpose of this study, using deep sequencing, is to evaluate for differential gene expression and alternative splicing associated with LPS treatment in human PBMCs.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308443">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE302606 SETD8 H4K20 å•ç”²åŸºè½¬ç§»é…¶çš„æŠ‘åˆ¶é™åˆ¶äº†å•çº¯ç–±ç–¹ç—…æ¯’æ„ŸæŸ“åŸºå› ç»„çš„å…¨å±€å¯åŠæ€§ [ATAC-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€TMEã€metabolismã€metabolicã€metabolomeã€gliomaã€kinaseã€resistanceã€TCGAã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scATACã€genomeã€genomicsã€epigenomeã€methylationã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jesse H Arbuckle ; Tovah E Markowitz ; Jodi L Vogel ; Thomas M KristieSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensEpigenetic modulation of herpes simplex virus (HSV) immediate early (IE) genes is a critical regulatory parameter governing lytic infection, latency, and viral reactivation. Multiple factors, including epigenetic complexes associated with the cellular transcriptional coactivator HCF-1, modulate the state of HSV-1 chromatin. As an approach to identify novel epigenetic factors that regulate the initial stage of HSV-1 infection, an epigenetic chemical probe library was screened for their impact on viral IE gene expression. This screen identified several epigenetic inhibitors that modulated IE expression. Notably, UNC0379, an inhibitor of the histone H4K20 mono-methyltransferase SETD8, potently repressed HSV-1 infection in vitro and in vivo. Furthermore, SETD8 inhibition suppressed HSV-1 reactivation in a mouse ganglia explant model. Importantly, these results correlated with enhanced heterochromatin suppression and decreased accessibility of HSV-1 chromatin. Reduced IE transcription was concomitant with disruption in recruitment of HCF-1 and RNA polymerase II (RNAPII). These results are consistent with the established roles of SETD8 in promoting chromatin accessibility through H4K20me1 deposition and regulating transcriptional elongation, suggesting that SETD8 may facilitate multiple steps in regulation of HSV-1 IE gene expression.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302606">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE275670 è¡¨å¾ç¼ºæ°§è°ƒæ§çš„å°‘çªèƒ¶è´¨ç»†èƒå‰ä½“ç»†èƒä¸­å’ä¸­åå˜åŒ–ï¼Œä»¥æ”¹è¿›å’ä¸­ç»†èƒç–—æ³•</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€gliomaã€TCGAã€DepMapã€depmapã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€genomeã€proteomeã€R packageã€Scanpyã€epigeneticã€epigenomeã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ken Yasuda ; Takakuni Maki ; Kazuto Tsukita ; Yasuhiro KuwataSeries Type : Expression profiling by high throughput sequencingOrganism : Rattus norvegicusOligodendrocyte precursor cells (OPCs) are traditionally known for their role in differentiating into oligodendrocytes, thereby contributing to myelination. Additionally, it has been increasingly recognized that OPCs actively modify their characteristics in response to the surrounding environment, exhibiting various other functions. However, how and when OPCs change their characteristics after acute ischemic stroke, and the contribution of these changes to post-stroke recovery, are not well understood. In this study, we aimed to transcriptionally characterize the changes in OPCs during acute ischemic stroke and develop therapies to support these changes. For this purpose, we first leveraged mouse single-cell RNA sequencing (scRNAseq) datasets to create a â€œmiddle cerebral artery occlusion (MCAO) atlas.â€ Crucially, we identified the distinct appearance of â€œangiogenicâ€ OPCs in the subacute phase and â€œoligogenicâ€ OPCs in the chronic phase after MCAO, contributing to angiogenesis and remyelination, respectively. Furthermore, we successfully induced OPCs ex vivo with similar functional characteristics to â€œangiogenicâ€ OPCs through severe hypoxic preconditioning. The intravenous transplantation of these hypoxia-preconditioned OPCs more efficiently promoted post-stroke angiogenesis, reduced infarct size, and improved neurological function after MCAO compared to normally treated OPCs. Finally, we demonstrated that mild hypoxia at least partially contributes to the generation of â€œoligogenicâ€ OPCs. Therefore, following acute ischemic stroke, OPCs sense oxygen levels and undergo phenotypic changes to exhibit functions required at specific times. Importantly, therapies supporting these phenotypic changes hold great promise for improving recovery from damage caused by acute ischemic stroke, for which current available treatments focus on quickly restoring blood flow.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275670">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE308968 LADA ä¸ 1 å‹ç³–å°¿ç—…å…ç–«è°±çš„å•ç»†èƒè½¬å½•ç»„å­¦æ¯”è¾ƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€immunityã€TMEã€gliomaã€single.cellã€single-cellã€scRNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€Seuratã€Scanpyã€epigenome</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Vadim ChechekhinSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensAutoimmune diabetes encompasses rapidly progressive type 1 diabetes mellitus (T1D) and indolent latent autoimmune diabetes in adults (LADA), yet the immunological drivers of this kinetic divergence remain unresolved. We performed single-cell RNA sequencing with paired T and B cell receptor profiling on over 400,000 peripheral blood mononuclear cells (PBMCs) from patients with LADA, newly diagnosed T1D, and healthy controls. PBMC composition was comparable across cohorts, indicating that qualitative rather than quantitative immune differences underlie disease heterogeneity. In T1D, pan-lineage activation of NF-kB, EGFR, MAPK, and hypoxia pathways, coupled with a TNF-centered communication hub, enhanced MHC signaling, and disrupted adhesion, promoted systemic inflammation. LADA, by contrast, exhibited global suppression of NF-kB/EGFR activity, retention of moderate JAK/STAT tone, reinforced natural killer cell inhibitory checkpoints via HLA-C-KIR2DL3/3DL1 interaction, and stabilized CD8+ T cell synapses through HLA-C-CD8 binding, collectively restraining effector activation. Single-cell V(D)J analysis revealed polyclonal, patient-unique adaptive repertoires, emphasizing the primacy of signaling context over receptor convergence. These findings define LADA and T1D as endpoints on an inflammatory-inhibitory spectrum and identify the NF-kB/EGFR-JAK/STAT gradient and HLA-C-KIR axis as potential therapeutic targets for preserving residual beta-cell function in autoimmune diabetes.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308968">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>GSE242906 è½¬å½•å› å­ ZNF263 å¯åŠ¨äººç±»èƒšèƒå¹²ç»†èƒçš„å¤šèƒ½æ€§ä¸§å¤±å’Œæ—©æœŸåˆ†åŒ–</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€immunityã€TMEã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€Seuratã€Scanpyã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Genome binding/occupancy profiling by high throughput sequencing ; Expression profiling by high throughput sequencingOrganism : Homo sapiensThis SuperSeries is composed of the SubSeries listed below.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE242906">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>GSE302607 SETD8 H4K20 å•ç”²åŸºè½¬ç§»é…¶çš„æŠ‘åˆ¶é™åˆ¶äº†å•çº¯ç–±ç–¹ç—…æ¯’æ„ŸæŸ“åŸºå› ç»„çš„å…¨å±€å¯åŠæ€§ [ChIP-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€TMEã€metabolismã€metabolicã€metabolomeã€resistanceã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€genomeã€genomicsã€epigenomeã€methylationã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jesse H Arbuckle ; Tovah E Markowitz ; Jodi L Vogel ; Thomas M KristieSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensEpigenetic modulation of herpes simplex virus (HSV) immediate early (IE) genes is a critical regulatory parameter governing lytic infection, latency, and viral reactivation. Multiple factors, including epigenetic complexes associated with the cellular transcriptional coactivator HCF-1, modulate the state of HSV-1 chromatin. As an approach to identify novel epigenetic factors that regulate the initial stage of HSV-1 infection, an epigenetic chemical probe library was screened for their impact on viral IE gene expression. This screen identified several epigenetic inhibitors that modulated IE expression. Notably, UNC0379, an inhibitor of the histone H4K20 mono-methyltransferase SETD8, potently repressed HSV-1 infection in vitro and in vivo. Furthermore, SETD8 inhibition suppressed HSV-1 reactivation in a mouse ganglia explant model. Importantly, these results correlated with enhanced heterochromatin suppression and decreased accessibility of HSV-1 chromatin. Reduced IE transcription was concomitant with disruption in recruitment of HCF-1 and RNA polymerase II (RNAPII). These results are consistent with the established roles of SETD8 in promoting chromatin accessibility through H4K20me1 deposition and regulating transcriptional elongation, suggesting that SETD8 may facilitate multiple steps in regulation of HSV-1 IE gene expression.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302607">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> â­ <strong>GSE307083 æ¢­é²ˆè„‘å‘è‚²è¿‡ç¨‹ä¸­è½¬å½•å› å­å’Œç¥ç»å…ƒæ•ˆåº”å™¨çš„å·®å¼‚æ´»æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€TMEã€gliomaã€TCGAã€scRNAã€scDNAã€scATACã€Visiumã€genomeã€transcriptomeã€proteomeã€Seuratã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Radka SymonovaSeries Type : Expression profiling by high throughput sequencingOrganism : Sander luciopercaJuvenile pikeperch (Sander lucioperca) undergo several ontogenetic shifts whose timing determines the survival of their first winter. The shift from a planktivorous phenotype to a more active predatory (piscivorous) behavior is accompanied by moving from pelagic to demersal habitat with much more stimuli and hence by potential brain functional reorganizations. During two consecutive years, we collected planktivores and piscivores, with different body sizes between the years recording distinct stages relative to the shift and analyzed their whole-brain transcriptomes framed by detailed ecological knowledge. The differential gene transcription analysis identified a distinct non-overlapping group of transcription factors (TFs) significantly upregulated in each phenotype: TFs upregulated in planktivores correspond to initial establishment of brain regions and overall architecture; TFs upregulated in piscivores correspond to the refinement of neuronal populations and the formation of specific neuronal circuits. The planktivorous phenotype independently of body size was characterized by interconnected activity of two TFs, fosab and junba. Gene set enrichment revealed extracellular matrix and collagen-related Gene Ontology terms in piscivores from both years. A highly increased activity of solute carrier (Slc) transporters was identified in the smaller-bodied piscivorous phenotype (20 members of 12 Slc families). The overall count of Slc genes transcribed in pikeperch brain was 334, which is higher than known for humans (287). The neurotranscriptomics results reflected differences in body size and matched with ecological data and survival rates. The multidimensional brain regulome indicated that the intra-phenotypic body size difference can translate into the specific gene activity of the brain in juvenile pikeperch. The period of transition to piscivory appears to be an important ontogenetic step accompanied by increased specific transcription activity.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307083">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> â­ <strong>GSE279266 é˜æ˜æŒ¥å‘æ€§æœ‰æœºåŒ–åˆç‰©å¯¹æ¤ç‰©ç—…åŸèŒç”˜è”—å­¢å­èŒæŠ‘åˆ¶ä½œç”¨çš„å½±å“</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€carcinomaã€TMEã€cardiacã€gliomaã€TCGAã€scRNAã€scDNAã€scATACã€Visiumã€genomeã€Seuratã€Scanpyã€epigenomeã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Mulato Aline Tieppo Nogueira ; Persinoti Gabriela FÃ©lix ; Oliveira Juliana Velasco de CastroSeries Type : Expression profiling by high throughput sequencingOrganism : Sporisorium scitamineumSugarcane holds substantial agricultural and industrial importance in Brazil and worldwide, primarily due to its use in biofuel production and for a range of biomolecules of diverse biochemical applications. The drive towards sustainable agricultural practices has fostered the interest in the exploration of bioproducts to reduce the dependence on agrochemicals. In this context, microbial volatile organic compounds (VOCs) have emerged as potential biofungicides, offering several advantages over conventional chemical treatments. This study focused on evaluating their antagonistic potential against Sporisorium scitamineum, the causative agent of sugarcane smut disease, and investigated the molecular mechanisms underlying their inhibitory effects. Two Pseudomonas bacterial strains isolated from sugarcane roots exhibited remarkable antagonistic activity against S. scitamineum. Notably, ITA P2F2 completely inhibited the growth of the phytopathogen and was identified as a novel species within the Pseudomonas genus. A total of 63 VOCs were identified from both bacterial isolates, with eight showing inhibitory activity against the phytopathogen. Transcriptomic analyses revealed significant changes in gene expression of S. scitamineum when exposed to VOCs from ITA P2F2, including the downregulation of genes involved in central metabolic pathways, such as carbohydrate metabolism and fatty acid Î²-oxidation, and the upregulation of genes associated with DNA repair. Potential DNA damage caused by the VOCs was further evidenced through temporal analysis using Fourier Transform Infrared (FTIR) spectroscopy. Additionally, electron microscopy analysis showed structural damage to the fungal hyphae after VOCs exposure. This multidisciplinary study is the first to investigate the inhibition of S. scitamineum using VOCs. Our findings contribute to the molecular understanding of these signaling molecules and highlight their potential as promising bioproducts to replace conventional agrochemicals in the control of sugarcane pathogens.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279266">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 15 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ”¬ æœŸåˆŠæ–‡ç«  (7æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨7æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨7æ¡ï¼‰</h4><p><strong>1.</strong> <strong>ä¸ ESR1 çªå˜è½¬ç§»æ€§ä¹³è…ºç™Œ elacestrant ç»“æœç›¸å…³çš„ä¸´åºŠå’ŒåŸºå› ç»„å› ç´ </strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šåŸºå› ç»„</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç›®çš„ï¼šESR1 çªå˜ä»‹å¯¼æ¿€ç´ å—ä½“é˜³æ€§è½¬ç§»æ€§ä¹³è…ºç™Œ ï¼ˆMBCï¼‰ å¯¹æŠ—é›Œæ¿€ç´ æ²»ç–—çš„è€è¯æ€§ã€‚Elacestrant æ˜¯ä¸€ç§å£æœé€‰æ‹©æ€§é›Œæ¿€ç´ å—ä½“é™è§£å‰‚ï¼Œä¸æ ‡å‡†å†…åˆ†æ³Œæ²»ç–—ç›¸æ¯”ï¼ŒESR1 çªå˜ MBC çš„æ— è¿›å±•ç”Ÿå­˜æœŸæ›´é«˜ã€‚æˆ‘ä»¬è¯„ä¼°äº†çœŸå®ä¸–ç•Œçš„ elacestrant ä½¿ç”¨æƒ…å†µå’Œä¸ç»“å±€ç›¸å…³çš„ä¸´åºŠåŸºå› ç»„å› ç´ ã€‚å®éªŒè®¾è®¡ï¼šæœ¬ç ”ç©¶ä½¿ç”¨ GuardantINFORM æ•°æ®åº“ï¼Œå°† >42,000 ä¾‹çœŸå®ä¸–ç•Œçš„ä¹³è…ºç™Œç—…ä¾‹ä¸æµ‹åºå’Œç´¢èµ”æ•°æ®è”ç³»èµ·æ¥ã€‚æˆ‘ä»¬çº³å…¥äº†åœ¨ elacestrant å¼€å§‹å‰ &lt;6 ä¸ªæœˆï¼ˆ2023 å¹´ 1 æœˆè‡³ 2024 å¹´ 3 æœˆï¼‰æ£€æµ‹åˆ°æ¿€æ´» ESR1 çªå˜çš„æ‚£è€…ã€‚ä½¿ç”¨ Kaplan-Meier å’Œ Cox å›å½’åˆ†æä¼°è®¡æ²»ç–—ä¸­æ­¢æ—¶é—´ï¼ˆTTDï¼‰ã€ä¸‹ä¸€æ¬¡æ²»ç–—æ—¶é—´ï¼ˆTTNTï¼‰å’Œæ€»ç”Ÿå­˜æœŸçš„ç»“æœï¼Œå¹¶è°ƒæ•´ä¸´åºŠå˜é‡ã€‚ç»“æœï¼šæˆ‘ä»¬ç¡®å®šäº† 756 åæ‚£è€…ï¼ˆ76% æ—¢å¾€æ¥å—è¿‡ CDK4/6 æŠ‘åˆ¶å‰‚ï¼Œ38% æ—¢å¾€æ¥å—è¿‡åŒ–ç–—ï¼‰ï¼Œå…¶ä¸­</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1987198766359359488/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>è¡°è€å¾®ç¯å¢ƒæ˜¯èƒ°è…ºç™Œå…ç–«æ’æ–¥å’Œè½¬ç§»å‘½è¿çš„å†³å®šå› ç´ </strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: è¡°è€æ˜¯èƒ°è…ºå¯¼ç®¡è…ºç™Œ ï¼ˆPDACï¼‰ é£é™©å’Œç»“æœä¸­ä¸€ä¸ªå…³é”®ä½†ç ”ç©¶ä¸è¶³çš„å†³å®šå› ç´ ã€‚å°½ç®¡ä¸å¹´é¾„æœ‰å¾ˆå¼ºçš„æµè¡Œç—…å­¦å…³è”ï¼Œä½†ä¼ ç»Ÿçš„ PDAC ä¸´åºŠå‰æ¨¡å‹æœªèƒ½æ•æ‰åˆ°è€å¹´ç”Ÿç‰©ä½“ä¸­å‡ºç°çš„ç»„ç»‡ç—…ç†å­¦å’ŒåŸºè´¨å¤æ‚æ€§ã€‚ä½¿ç”¨ä¸å¹´é¾„ç›¸å…³çš„åŒåŸºå› åŸä½æ¨¡å‹ï¼Œæˆ‘ä»¬è¯æ˜äº†ç”Ÿç‰©ä½“è¡°è€åŠ é€Ÿäº† PDAC çš„è¿›å±•å’Œè½¬ç§»ã€‚è½¬å½•ç»„å­¦å’Œåˆ†æ³Œç»„åˆ†æç¡®å®šäº†å¯Œé›†äºè€å¹´è‚¿ç˜¤ç™Œç—‡ç›¸å…³æˆçº¤ç»´ç»†èƒ ï¼ˆCAFï¼‰ ä¸­çš„ä¿å®ˆç»†èƒå¤–åŸºè´¨åŸºå› ç‰¹å¾ï¼Œä¸æ”¯æŒå…ç–«æŠ‘åˆ¶ã€è½¬ç§»æ€§è¶‹æ€§å’Œä¸è‰¯é¢„åçš„å¢å¼ºçº¤ç»´åŒ–æ™¯è§‚ä¸€è‡´ã€‚åœ¨å¼‚æ…¢æ€§å…±æ¤å…¥æ¨¡å‹ä¸­å¯¹åŸºè´¨è€åŒ–çš„åŠŸèƒ½å½±å“çš„ç›´æ¥æµ‹è¯•è¡¨æ˜ï¼Œç”¨å¹´è½»çš„ CAF æ´»åŒ–è€åŒ–çš„è‚¿ç˜¤åŸºè´¨å¯ä»¥æ¢å¤å…ç–«æµ¸æ¶¦å¹¶å‡è½»è€å¹´å®¿ä¸»çš„è½¬ç§»ã€‚ç›¸åï¼Œè€å¹´ CAF è™½ç„¶å…·æœ‰å…ç–«æŠ‘åˆ¶ä½œç”¨ï¼Œä½†æœªèƒ½å¢å¼ºå¹´è½»å®¿ä¸»çš„è½¬ç§»ï¼Œè¿™è¡¨æ˜å¹´è½»çš„å¾®ç¯å¢ƒå¯¹ç–¾ç—…è¿›å±•æ–½åŠ äº†ä¸»å¯¼çš„è°ƒèŠ‚æ§åˆ¶ã€‚è¿™äº›å‘ç°è¡¨æ˜ï¼ŒåŸºè´¨å¹´é¾„æ˜¯ PDAC ä¸­å…ç–«æ’é™¤å’Œè½¬ç§»è¡Œä¸ºçš„å…³é”®è°ƒèŠ‚å› å­ã€‚é‡è¦çš„æ˜¯ï¼Œè¿™é¡¹å·¥ä½œä¸ºç†è§£è¡°è€å¦‚ä½•å¡‘é€  PDAC</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1987247448505036800/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>å¤šåŸºå› ç»„åˆå’Œ pembrolizumab è¦†ç›–ç‡å¯¹è½¬ç§»æ€§é»‘è‰²ç´ ç˜¤æ‚£è€…å’Œäººç¾¤çš„å½±å“</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šåŸºå› ç»„</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: èƒŒæ™¯ é¶å‘æ²»ç–—æˆ–å…ç–«æ²»ç–—å¯èƒ½ä¼šä¸ºé»‘è‰²ç´ ç˜¤æ‚£è€…å¸¦æ¥å¢åŠ ã€æŒä¹…çš„ååº”ã€‚æ‚£è€…å±‚é¢çš„ç›Šå¤„æ˜¯å¦èƒ½è½¬åŒ–ä¸ºäººå£å¥åº·å°šä¸æ¸…æ¥šã€‚æœ¬ç ”ç©¶æ—¨åœ¨ä¼°è®¡ç™Œç—‡æ§åˆ¶æ”¿ç­–å¯¹æ‚£è€…å’Œäººç¾¤çš„å½±å“ï¼Œè¯¥æ”¿ç­–æŠ¥é”€äº†åŠ æ‹¿å¤§ä¸åˆ—é¢ å“¥ä¼¦æ¯”äºšçœè½¬ç§»æ€§é»‘è‰²ç´ ç˜¤çš„å¤šåŸºå› é¢æ¿æ£€æµ‹å’Œå¸•åšåˆ©ç å•æŠ—ã€‚æ–¹æ³• è¿™é¡¹å›é¡¾æ€§ç ”ç©¶æ£€æŸ¥äº† 2013 å¹´è‡³ 2018 å¹´é—´æ¥å—å•åŸºå› æˆ–å¤šåŸºå› æ£€æµ‹çš„ä¸åˆ—é¢ å“¥ä¼¦æ¯”äºšçœ 721 åè¢«è¯Šæ–­æ‚£æœ‰è½¬ç§»æ€§é»‘è‰²ç´ ç˜¤çš„æˆå¹´äººçš„äººç¾¤é˜Ÿåˆ—ã€‚æˆ‘ä»¬ä½¿ç”¨ 11 ç§é—ä¼ ç®—æ³•å°†å—æ”¿ç­–å½±å“çš„æ‚£è€…ä¸å†å²å¯¹ç…§è¿›è¡ŒåŒ¹é…ï¼Œä»¥åŠ Kaplan-Meier åˆ†æå’Œä¸¤å¹´åŒ»ç–—è´¹ç”¨å’Œç”Ÿå­˜æ—¶é—´çš„åˆ å¤±åŠ æƒå›å½’çš„é€†æ¦‚ç‡æ¥ç¡®å®šæ‚£è€…æ°´å¹³çš„æ”¿ç­–å½±å“ã€‚å¯¹äºäººå£æ°´å¹³çš„å½±å“ï¼Œæˆ‘ä»¬å¯¹æ¯æœˆå«ç”Ÿç³»ç»Ÿæ”¯å‡ºå’Œæ­»äº¡ç‡åº”ç”¨äº†ä¸­æ–­æ—¶é—´åºåˆ—åˆ†æï¼Œä¼°è®¡äº† ARIMA å’Œå¹¿ä¹‰æœ€å°äºŒä¹˜æ³Šæ¾å›å½’ã€‚ç»“æœ åŒ¹é…é˜Ÿåˆ—åˆ†æï¼ˆncontrol = 154ï¼Œnintervention = 154ï¼‰å‘ç°æ‚£è€…æ°´å¹³å¹³å‡ç´¯è®¡æˆæœ¬å¢åŠ  53</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1987567612756865024/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>é™çº§è¯•éªŒå¹¶ä¸æ€»æ˜¯éœ€è¦éåŠ£æ•ˆæ€§â€”â€”è‚¿ç˜¤å­¦ä¼˜è¶Šæ€§è®¾è®¡é™çº§è¯•éªŒçš„ä¸€ä¸ªæ¡ˆä¾‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: è‚¿ç˜¤å­¦é™çº§è¯•éªŒæœ€è¿‘å—åˆ°è¶Šæ¥è¶Šå¤šçš„å…³æ³¨ï¼Œå› ä¸ºäººä»¬è¶Šæ¥è¶Šæ‹…å¿ƒç™Œç—‡æ‚£è€…æ­£åœ¨æ¥å—è¿‡åº¦æ²»ç–—â€”â€”æ›´å¤šçš„æ‚£è€…ï¼ˆè€Œä¸æ˜¯å—ç›Šçš„æ‚£è€…ï¼‰åœ¨ç—…ç¨‹çš„æ—©æœŸæ¥å—æ²»ç–—ï¼Œå‰‚é‡æ›´é«˜ï¼ŒæŒç»­æ—¶é—´æ›´é•¿ï¼Œé¢‘ç‡æ›´é«˜ã€‚å› æ­¤ï¼Œé‡è¦çš„æ˜¯è¦äº†è§£è¾ƒå°‘çš„æ²»ç–—æ˜¯å¦èƒ½è®©æˆ‘ä»¬è¾¾åˆ°ç±»ä¼¼çš„ç»“æœï¼Œè¿™ç§ç­–ç•¥ç§°ä¸ºé™çº§æ²»ç–—ã€‚ç„¶è€Œï¼Œè¿™ç§é™çº§ç­–ç•¥çš„ä¸»è¦é—®é¢˜ä¹‹ä¸€æ˜¯å¯èƒ½ä¼šæŸå®³æ²»ç–—æ•ˆæœã€‚è™½ç„¶ä»¥è¾ƒå°çš„æ²»ç–—è´Ÿæ‹…é™çº§æ²»ç–—æœ¬èº«å°±æ˜¯ä¸€ä¸ªå€¼å¾—çš„ç›®æ ‡ï¼Œå› ä¸ºå®ƒå¯ä»¥å‡å°‘èº«ä½“ã€ç»æµå’Œæ—¶é—´æ¯’æ€§ï¼Œä½†é™çº§ä¸èƒ½ä»¥å¤§å¹…å½±å“æ²»ç–—æ•ˆæœä¸ºä»£ä»·ã€‚æµ‹è¯•æ­¤ç±»é™çº§ç­–ç•¥æ˜¯å¦å®‰å…¨ä¸”ä¸ä¼šå¯¼è‡´ä¸å¯æ¥å—çš„ç–—æ•ˆå¦¥åçš„æœ€å¸¸è§æ–¹æ³•æ˜¯é€šè¿‡éåŠ£æ•ˆæ€§è®¾è®¡è¯•éªŒã€‚æ­¤ç±»è¯•éªŒéœ€è¦æ›´å¤§çš„æ ·æœ¬é‡ï¼Œå› æ­¤éœ€è¦æ›´å¤šçš„èµ„é‡‘å’Œæ›´é•¿çš„å®Œæˆæ—¶é—´ã€‚ç„¶è€Œï¼Œé™çº§è¯•éªŒä¸ä¸€å®šéœ€è¦éåŠ£æ•ˆæ€§è®¾è®¡ã€‚åœ¨æœ¬æ–‡ä¸­ï¼Œæˆ‘æå‡ºäº†ä½¿ç”¨ä¼˜åŠ¿è®¾è®¡æ¥æµ‹è¯•é™çº§ç­–ç•¥çš„æ¡ˆä¾‹ã€‚è¿™å°†é¿å…éåŠ£æ•ˆæ€§è®¾è®¡çš„å±€é™æ€§ï¼Œå¹¶ä½¿é™çº§ç­–ç•¥çš„æµ‹è¯•æ›´åŠ æœ‰æ•ˆã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1987567801429241856/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>è‹±å›½å¯äº¤ä»˜çš„å›½å®¶ç™Œç—‡æ§åˆ¶è®¡åˆ’ï¼šå›½å¤–çš„ç»éªŒæ•™è®­å’Œå›½å†…çºªå¾‹çš„å¿…è¦æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: æš‚æ— æ‘˜è¦</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1987039360174895104/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>è¡°è€ç›¸å…³åˆ†æ³Œè¡¨å‹ ï¼ˆSASPï¼‰ åœ¨ç™Œç—‡æ²»ç–—ä¸­çš„äº‰è®®ä½œç”¨</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç»†èƒè¡°è€ä»¥éƒ¨åˆ†ä¸å¯é€†çš„ç»†èƒå‘¨æœŸåœæ»ä¸ºç‰¹å¾ï¼Œé€šè¿‡è¡°è€ç›¸å…³åˆ†æ³Œè¡¨å‹ ï¼ˆSASPï¼‰ åœ¨ç™Œç—‡è¿›å±•ä¸­å‘æŒ¥åŒé‡ä½œç”¨ã€‚SASP åŒ…å«å¤šç§ç”Ÿç‰©æ´»æ€§åŒ–å­¦ç‰©è´¨ï¼ŒåŒ…æ‹¬ç»†èƒå› å­ã€è¶‹åŒ–å› å­ã€ç”Ÿé•¿å› å­å’Œè›‹ç™½é…¶ï¼Œæ‰€æœ‰è¿™äº›éƒ½ä¼šå¯¹è‚¿ç˜¤å¾®ç¯å¢ƒ ï¼ˆTMEï¼‰ äº§ç”Ÿé‡å¤§å½±å“ã€‚æœ€åˆï¼ŒSASP å¯ä»¥é€šè¿‡å¸å¼•å…ç–«ç»†èƒå’ŒæŠ‘åˆ¶ç™Œç»†èƒå¢æ®–æ¥å¢å¼ºè‚¿ç˜¤æŠ‘åˆ¶ï¼Œä½†å…¶åœ¨ TME çš„é•¿æœŸå­˜åœ¨å¯ä»¥ä¿ƒè¿›è‚¿ç˜¤çš„ç”Ÿé•¿ã€è½¬ç§»å’Œæ²»ç–—è€è¯æ€§ã€‚æ­¤å¤–ï¼Œæ²»ç–—å¼•èµ·çš„è¡°è€æ˜¯ç™Œç—‡æ²»ç–—çš„å¸¸è§å‰¯ä½œç”¨ï¼Œå¯å¯¼è‡´è¡°è€ç»†èƒå’Œä¿ƒè‚¿ç˜¤ SASP å¢åŠ ã€‚å› æ­¤ï¼Œæœ€è¿‘çš„ç ”ç©¶å¼ºè°ƒäº†é¶å‘ SASP æ”¹å–„ç™Œç—‡æ²»ç–—çš„æ½œåŠ›ã€‚åœ¨æ²»ç–—ç­–ç•¥ä¸­ï¼Œè¡°è€ç–—æ³•é€‰æ‹©æ€§åœ°æ¶ˆé™¤è¡°è€ç»†èƒï¼Œè€Œè¡°è€è¯ç‰©é™ä½ SASP è€Œæ²¡æœ‰ç»†èƒæ¯’æ€§ï¼Œä¹Ÿæœ‰é¶å‘ SASP çš„è”åˆç–—æ³•è¿›è¡Œè‚¿ç˜¤æ²»ç–—ã€‚å› æ­¤ï¼Œå¼€å‘æ›´ç‰¹å¼‚æ€§çš„è€å¹´äººæ²»ç–—è¯ç‰©å¹¶ç ”ç©¶ SASP è°ƒèŠ‚çš„ä¸´åºŠåº”ç”¨è‡³å…³é‡è¦ï¼Œä¾‹å¦‚ä½¿ç”¨ SASP æˆåˆ†ä½œä¸ºæ²»ç–—ç›‘æµ‹å’Œä¸ªæ€§åŒ–åŒ»ç–—çš„ç”Ÿç‰©æ ‡å¿—ç‰©ã€‚æ€»è€Œè¨€ä¹‹ï¼Œäº†è§£ SASP</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1987038335619674112/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>æ¥å—ç™Œç—‡æ²»ç–—çš„æ‚£è€…çš„è™šå¼±ä¸æ˜æ˜¾æ›´å¤šçš„ä¸è‰¯åæœæœ‰å…³</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç ”ç©¶äººå‘˜æ—©å°±çŸ¥é“è™šå¼±ä¸æ›´ç³Ÿç³•çš„ç™Œç—‡ç»“æœæœ‰å…³ã€‚ä¸€åŠçš„ç™Œç—‡è€å¹´äººä»¥åŠä¸€äº›å¹´è½»ç™Œç—‡æ‚£è€…éƒ½æ‚£æœ‰è™šå¼±ï¼Œè¿™è¢«å®šä¹‰ä¸ºç”Ÿç‰©å‚¨å¤‡çš„ä¸§å¤±ï¼Œä½¿äººä»¬æ›´å®¹æ˜“å—åˆ°èº«ä½“å‹åŠ›çš„å½±å“ã€‚å…ˆå‰çš„ç ”ç©¶è¡¨æ˜ï¼Œè™šå¼±é€šå¸¸ä¸ä¸ç™Œç—‡æ²»ç–—ç›¸å…³çš„æ¯’æ€§å’Œæ­»äº¡é£é™©å¢åŠ æœ‰å…³ã€‚ ä¸´åºŠåŒ»ç”Ÿéœ€è¦æœ‰æ•ˆçš„ç­›æŸ¥å·¥å…·æ¥ç¡®å®šå“ªäº›ç™Œç—‡æ‚£è€…æœ‰è™šå¼±å’Œä¸è‰¯é¢„åçš„é£é™©ã€‚è¿™äº›ä¿¡æ¯å¯ä»¥å¸®åŠ©ä»–ä»¬ç¡®å®šé€‚åˆæ¯ä½æ‚£è€…çš„æœ€ä½³æ–¹æ¡ˆã€‚ å°½ç®¡å­˜åœ¨å¤šç§è¡°å¼±ç­›æŸ¥å·¥å…·ï¼Œä½†è€å¹´ 8 ï¼ˆG8ï¼‰ è€å¹´ç­›æŸ¥å·¥å…·æ˜¯å”¯ä¸€ä¸€ç§ç»è¿‡è¯„ä¼°å’Œç³»ç»Ÿè¯„ä»·çš„é¢„åèƒ½åŠ›å·¥å…·ã€‚G8 è¯„ä¼°å…«ä¸ªé¢†åŸŸï¼šå¹´é¾„ã€é£Ÿç‰©æ‘„å…¥é‡ã€æ´»åŠ¨èƒ½åŠ›ã€ä½“é‡å‡è½»ã€ä½“é‡æŒ‡æ•°ã€å¤„æ–¹è¯æ•°é‡ã€ç¥ç»å¿ƒç†çŠ¶å†µå’Œè‡ªæˆ‘æŠ¥å‘Šçš„å¥åº·çŠ¶å†µã€‚ åœ¨å‘è¡¨åœ¨ã€Š ç¾å›½å›½å®¶ç™Œç—‡ç ”ç©¶æ‰€æ‚å¿— ã€‹ï¼ˆdoiï¼š10.1093/jnci/djaf017ï¼‰ä¸Šçš„ä¸€é¡¹ç ”ç©¶ä¸­ï¼Œç ”ç©¶äººå‘˜å¯¹ 58 é¡¹ç ”ç©¶è¿›è¡Œäº†èŸèƒåˆ†æï¼Œç»¼åˆå¹¶æ€»ç»“äº†æœ‰å…³è¡°å¼±è¯„ä¼°å·¥å…·ä¸æˆäººç™Œç—‡æ²»ç–—ç»“æœä¹‹é—´å…³è”çš„å½“å‰è¯æ®æ‚£æœ‰ç™Œç—‡ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1987054358318133248/t>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (1æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨1æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4><p><strong>1.</strong> <strong>@ellis2013nz æä¾›çš„ç¦»æ•£æ•°æ®é›¶å‡è®¾ä¸‹ p å€¼åˆ†å¸ƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€Seurat</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šMotivation A few months back in a side skirmish during the great p-curve controversy, Richard McElreath mentioned that p-values under the null hypothesis are not always uniformly distributed, as is sometimes claimed. This prompted me to check out the &mldr; Continue reading: Distribution of p-values under the null hypothesis for discrete data by @ellis2013nz</li><li>ğŸ”— <a href=https://www.r-bloggers.com/2025/11/distribution-of-p-values-under-the-null-hypothesis-for-discrete-data-by-ellis2013nz/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>TME</td><td>28</td></tr><tr><td>scRNA</td><td>21</td></tr><tr><td>scATAC</td><td>19</td></tr><tr><td>cancer</td><td>18</td></tr><tr><td>Seurat</td><td>18</td></tr><tr><td>scDNA</td><td>17</td></tr><tr><td>genome</td><td>17</td></tr><tr><td>TCGA</td><td>15</td></tr><tr><td>tumor</td><td>13</td></tr><tr><td>immune</td><td>12</td></tr><tr><td>glioma</td><td>12</td></tr><tr><td>genomics</td><td>10</td></tr><tr><td>resistance</td><td>10</td></tr><tr><td>single.cell</td><td>9</td></tr><tr><td>RNAseq</td><td>9</td></tr><tr><td>spatial</td><td>8</td></tr><tr><td>epigenome</td><td>8</td></tr><tr><td>histone</td><td>8</td></tr><tr><td>carcinoma</td><td>7</td></tr><tr><td>cardiac</td><td>7</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-å…¬ä¼—å·></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (8æ¡)</summary><div class=details-content markdown=1><ul><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503915&amp;idx=1&amp;sn=8a4b3694b25a6dadb51cb8c1a33c10f7">10+ç”Ÿä¿¡ï¼ŒåŸºäº Ro/e å‘ç°ä¸åŒæ²»ç–—ååº”æ‚£è€… CD8Teff ç»†èƒæ¯”ä¾‹å·®å¼‚ã€‚ç»†èƒä¸°åº¦åˆ†æè¯†åˆ«å…³é”®ç»†èƒç›®å‰åœ¨é«˜åˆ†æ–‡ç« ä¸­å¾ˆå¸¸è§ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzNzY2NDgyOQ==&amp;mid=2247493127&amp;idx=1&amp;sn=72c80827af7e822864c6d30a0e165a0a">ä½¿ç”¨metaå’ŒmetasensåŒ…è¿›è¡Œmetaåˆ†æçš„å®ç”¨æ•™ç¨‹</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzI5NjUyNzkxMg==&amp;mid=2247498170&amp;idx=1&amp;sn=539030e4e508259a246cf0dfa58a4a07">ä¸ºäº†ä¸Šè¯¾ï¼Œç»™Swiss-Modelå†™ä¸ªRåŒ…å§</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509261&amp;idx=3&amp;sn=e7d9bd134dd66b7035e70c04a3fc010a">å…‹æœåŒ–ç–—è€è¯æ€§çš„å¯è½¬åŒ–ç­–ç•¥ï¼å¾å·åŒ»ç§‘å¤§å­¦ç­‰å•ä½åˆä½œå‘æ–‡ï¼šæœ‰å‰æ™¯çš„è‚ºç™Œæ²»ç–—é¶ç‚¹</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzMzY5NDk3NA==&amp;mid=2247493188&amp;idx=1&amp;sn=b4e8f4c8915ceb31b8bf1329a10318d8">åˆ·æ–°è®¤çŸ¥ï¼æˆ‘å›½åšå£«å†³å®šå‘½è¿çš„ä¸€æ¬¡Natureå‘æ–‡ï¼Œåœ¨è‚¿ç˜¤é¢†åŸŸä¸€æˆ˜å°ç¥ï¼æå‰é¢„å®šè¯ºå¥–ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503130&amp;idx=1&amp;sn=06f045d31bc99a125aec66878653d3de">AI | Nature Medicine | åŒ»å­¦ä¸­çš„ç”Ÿæˆå¼äººå·¥æ™ºèƒ½</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2MDY1NTYyOQ==&amp;mid=2247498845&amp;idx=1&amp;sn=d0252da356d8588bcca82bbe6852d918">å•ç»†èƒç©ºé—´è”åˆåˆ†ææ–°è´µ&ndash;iStar</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzI4MjY5ODI1Nw==&amp;mid=2247496450&amp;idx=1&amp;sn=85e0207f182e8e7af071243e46ff9de1">Cell Report Medicineï¼šæ•°å­—ç—…ç†å­¦ä¹‹æ–°å‹è‚ºç™Œè¯Šæ–­å’Œé¢„åç®—æ³•çš„å¼€å‘</a></li></ul></div></details><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (15æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305887">GSE305887 Aiolos å¯¹è™šæ‹Ÿè®°å¿† T ç»†èƒåˆ†åŒ–å’ŒåŠŸèƒ½çš„å½±å“ [ATAC-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304702">GSE304702 ç›´æ¥ RNA æµ‹åºå’Œä¿¡å·æ¯”å¯¹æ­ç¤ºçœŸæ ¸ç»†èƒä¸­çš„ RNA ç»“æ„é›†åˆ [nanopore_DRS]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284441">GSE284441 Aiolos å¯¹è™šæ‹Ÿè®°å¿† T ç»†èƒåˆ†åŒ–å’ŒåŠŸèƒ½çš„å½±å“ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304703">GSE304703 ç›´æ¥ RNA æµ‹åºå’Œä¿¡å·æ¯”å¯¹æ­ç¤ºçœŸæ ¸ç»†èƒä¸­çš„ RNA ç»“æ„é›†åˆ [RNA004]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281636">GSE281636 ä¸€ç§æ–°å‹éNADåŸºPARP1æŠ‘åˆ¶å‰‚Japoflavone Bé€šè¿‡ROS/p38/p53é€šè·¯è§¦å‘éå°ç»†èƒè‚ºç™Œä¸­Caspase-3/GSDMEä»‹å¯¼çš„ç»†èƒç„¦äº¡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309111">GSE309111 ç›´æ¥ RNA æµ‹åºå’Œä¿¡å·æ¯”å¯¹æ­ç¤ºçœŸæ ¸ç»†èƒä¸­çš„ RNA ç»“æ„é›†åˆ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303560">GSE303560 ç›´æ¥ RNA æµ‹åºå’Œä¿¡å·æ¯”å¯¹æ­ç¤ºçœŸæ ¸ç»†èƒä¸­çš„ RNA ç»“æ„é›†åˆ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309271">GSE309271 N1-ç”²åŸºå‡å°¿è‹·ç›´æ¥è°ƒèŠ‚ç¿»è¯‘åŠ¨åŠ›å­¦</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217734">GSE217734 ç¾Šè†œæ¥æºçš„è¡€æ¸…æ·€ç²‰æ ·è›‹ç™½A1å‚ä¸åˆ†å¨©æ—¶èƒè†œçš„æ— èŒæ€§ç‚ç—‡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305888">GSE305888 Aiolos å¯¹è™šæ‹Ÿè®°å¿† T ç»†èƒåˆ†åŒ–å’ŒåŠŸèƒ½çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288733">GSE288733 åˆ©ç”¨è…ºç›¸å…³ç—…æ¯’åœ¨ä½“å†…å°†é¢„æ ‡è®°çš„æ˜Ÿå½¢èƒ¶è´¨ç»†èƒè½¬åŒ–ä¸ºç¥ç»å…ƒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306070">GSE306070 HSD17B1å¤±æ´»çªå˜å¯¹æˆå¹´å°é¼ åµå·¢åŸºå› è¡¨è¾¾çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292630">GSE292630 å•æ ¸ç»†èƒå¯¹æœºä½“èƒ½é‡ç¨³æ€çš„æ§åˆ¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300412">GSE300412 SOX2 æ˜¯å°é¼  NUT ç™Œå‘ç”Ÿè¿‡ç¨‹ä¸­ä¸€ä¸ªéå¿…éœ€çš„è°ƒèŠ‚å› å­</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293309">GSE293309 å°é¼  E15.5 è‚¾è„è¡¨è¾¾ IlkT173I æˆ– IlkWT çš„æ•°æ®</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-10 21:43</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week462025/ rel=tag>Week462025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-11-10/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-10</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-11-12/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-12</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-12/>ç§‘ç ”æ—¥æŠ¥ 2026-02-12</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-11/>ç§‘ç ”æ—¥æŠ¥ 2026-02-11</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-10/>ç§‘ç ”æ—¥æŠ¥ 2026-02-10</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-09/>ç§‘ç ”æ—¥æŠ¥ 2026-02-09</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-08/>ç§‘ç ”æ—¥æŠ¥ 2026-02-08</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (105)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (105)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>